Publicacións en colaboración con investigadores/as de Universidade de Vigo (23)

2023

  1. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature

    Chronobiology International, Vol. 40, Núm. 1, pp. 63-82

  2. Erythematous-violaceous and bullous skin lesions after administration of iodinated contrast in a patient on hemodialysis. A case of fixed drug eruption due to iodinated contrast

    Nefrologia

  3. Erythematous-violaceous and bullous skin lesions after administration of iodinated contrast in a patient on hemodialysis. A case of fixed drug eruption due to iodinated contrast

    Nefrologia

2021

  1. Ambulatory blood pressure monitoring-based definition of true arterial hypertension

    Minerva Medica, Vol. 111, Núm. 6, pp. 573-588

  2. Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 953-961

  3. Guidelines for the design and conduct of human clinical trials on ingestion-time differences–chronopharmacology and chronotherapy–of hypertension medications

    Chronobiology International, Vol. 38, Núm. 1, pp. 1-26

2020

  1. Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials.

    Chronobiology International, pp. 1-10

  2. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

    European heart journal, Vol. 41, Núm. 48, pp. 4565-4576

  3. Does Timing of Antihypertensive Medication Dosing Matter?

    Current Cardiology Reports, Vol. 22, Núm. 10

  4. New perspectives on the definition, diagnosis, and treatment of true arterial hypertension

    Expert Opinion on Pharmacotherapy, Vol. 21, Núm. 10, pp. 1167-1178

2019

  1. Asleep (not night-time) blood pressure as prognostic marker of cardiovascular risk

    European Heart Journal

  2. Publisher Correction: Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection (Nature Genetics, (2018), 50, 3, (381-389), 10.1038/s41588-018-0059-2)

    Nature Genetics

2018

  1. Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention

    European Heart Journal, Vol. 39, Núm. 47, pp. 4159-4171

  2. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection

    Nature Genetics, Vol. 50, Núm. 3, pp. 381-389

  3. Diálisis peritoneal: ¿un factor de riesgo o de protección para la encefalopatía posterior reversible (PRES)? Revisión de la literatura

    Nefrologia

2016

  1. Moyamoya angiopathy with postpartum onset. A case report and literature review

    Neurologia Argentina, Vol. 8, Núm. 3, pp. 187-191

2014

  1. Líquido peritoneal turbio no infeccioso secundario a lercanidipino

    Nefrologia

  2. Proteomics analysis of the peritoneal dialysate effluent reveals the presence of calciumregulation proteins and acute inflammatory response

    Clinical Proteomics, Vol. 11, Núm. 1

2013

  1. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals

    Chronobiology International, Vol. 30, Núm. 3, pp. 355-410

  2. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease

    Chronobiology International, Vol. 30, Núm. 1-2, pp. 159-175